Cost-effectiveness of alternative strategies for vaccination of adolescents against serogroup B IMD with the MenB-FHbp vaccine in Canada
Bibliographic Data
| ID | 8900480 |
|---|---|
| Authors | Marie-Claude Breton (Pfizer (Canada), corresponding author), Liping Huang (0000-0003-3073-7698, Pfizer (United States)), Sonya J Snedecor (0000-0002-0206-8522, Pharmerit (United States)), Noelle Cornelio (Pharmerit (United States)), Fiorella Fanton-Aita (Pfizer (Canada)) |
| Year | 2020 |
| Volume | 111 |
| Issue | 2 |
| Pages | 182-192 |
| Publication date | 2020-01-06 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Canadian Journal of Public Health (JOURNAL) |
| Journal identifiers | ISSN: 0008-4263 • E-ISSN: 1920-7476 |
| Publisher | Springer Science+Business Media (PUBLISHER • DE) |
| DOI | 10.17269/s41997-019-00275-4 |
| PMID | 31907760 |
| OpenAlex | W3000640454 |
| Language | EN |
| Citations received | 1 |
| References cited | 38 |
Our model indicated that if the vaccine reduces risk of carriage acquisition, vaccination of older adolescents, even at lower uptake, could have a significant public health impact. Due to low disease incidence, MnB vaccination is unlikely to meet widely accepted cost-effectiveness thresholds, but evaluations of new programs should consider the overall benefits of the vaccination
Carriage · Cost effectiveness · Environmental health · Immunization · Incidence (geometry · Population · Transmission (telecommunications · Vaccination · Bacterial Infections and Vaccines · Demography · Immunology · Influenza Virus Research Studies · Medicine · Pneumonia and Respiratory Infections · Pediatrics
| Citations per year | 1 |
|---|---|
| Citation span | 2025 - 2025 (1) |
| Highly cited | No |